9/21/2023  9:59:58 PM Chg. -0.59 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
19.31USD -2.96% 39,055
Turnover: 757,964.42
-Bid Size: - -Ask Size: - 4.18 bill.USD - 42.91

Business description

Neogen Corporation (Nasdaq: NEOG) develops and markets products dedicated to food and animal safety. Neogen’s Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Management board & Supervisory board

John Adent
Management board
David Naemura (ab 2.01.2023), Steven J. Quinlan (bis 1.01.2023), Amy M. Rocklin, Douglas E. Jones, Dr. Jason W. Lilly, Dr. Robert S. Donofrio, Jerome Hagedorn, Joseph A. Corbett, Julie L. Mann, Marylinn Munson, Shane M. Fitzwater
Supervisory board
James C. Borel, Aashima Gupta, Catherine E. Woteki, Darci L. Vetter, James P. Tobin, Jeffrey Capello, Ralph A. Rodriguez, Ronald Green, William T. Boehm

Company data

Name: Neogen Corp.
Address: 620 Lesher Place,Lansing, Michigan 48912, USA
Phone: +1-517-372-9200
Fax: +1-517-372-2006
E-mail: corporate@neogen.com
Internet: www.neogen.com
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 5/31
Free Float: 60.89%
IPO date: -

Investor relations

Name: Steven J. Quinlan
IR phone: +1-517-372-2280
IR Fax: -
IR e-mail: ir@neogen.com

Main Shareholders

Brown Capital Management, LLC
Black Rock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Wasatch Advisors, Inc.